Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 15.70 is 312% above its 5-year average of 3.81, around the middle of its 5-year range (0.05–37.75).
As of the fiscal period ended Tuesday, June 30, 2026. 20.94% above its 12-month average of 12.98.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 15.70.
CURRENT RATIO
15.70
CURRENT RATIO AVG TTM
12.98
CURRENT RATIO AVG 3Y
3.39
CURRENT RATIO AVG 5Y
3.81
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+20.94%
CURRENT VS 3Y AVG
+363.23%
CURRENT VS 5Y AVG
+312.01%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.34
median of 517 covered companies
CURRENT VS SECTOR MEDIAN
+369.93%
vs the sector median at left
Canton Strategic Holdings Inc
Market Cap
$180.47M
Current Ratio
15.70
TTM Avg
12.98
3Y Avg
3.39
5Y Avg
3.81
Market Cap
$178.29M
Current Ratio
11.22
TTM Avg
14.99
3Y Avg
15.44
5Y Avg
13.43
Market Cap
$178.17M
Current Ratio
12.82
TTM Avg
9.83
3Y Avg
6.43
5Y Avg
5.45
Market Cap
$184.12M
Current Ratio
1.59
TTM Avg
1.58
3Y Avg
1.42
5Y Avg
1.43
Market Cap
$198.09M
Current Ratio
14.32
TTM Avg
7.65
3Y Avg
9.22
5Y Avg
9.58
Market Cap
$195.29M
Current Ratio
7.90
TTM Avg
9.91
3Y Avg
10.86
5Y Avg
18.34
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canton Strategic Holdings Inc (CNTN) | $180.47M | 15.70 | 12.98 | 3.39 | 3.81 |
| Compass Therapeutics, Inc. (CMPX)vs › | $178.29M | 11.22 | 14.99 | 15.44 | 13.43 |
| Precision BioSciences, Inc. (DTIL)vs › | $178.17M | 12.82 | 9.83 | 6.43 | 5.45 |
| Journey Medical Corporation (DERM)vs › | $184.12M | 1.59 | 1.58 | 1.42 | 1.43 |
| Cue Biopharma, Inc. (CUE)vs › | $175.94M | 1.25 | 2.29 | 3.57 | 4.16 |
| Coherus Oncology, Inc. (CHRS)vs › | $174.59M | 1.77 | 1.33 | 1.71 | 2.63 |
| AN2 Therapeutics, Inc. (ANTX)vs › | $198.09M | 14.32 | 7.65 | 9.22 | 9.58 |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $195.29M | 7.90 | 9.91 | 10.86 | 18.34 |
| Inogen, Inc. (INGN)vs › | $160.82M | 2.74 | 2.77 | 3.26 | 3.97 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $158.11M | 9.71 | 4.67 | 6.04 | 19.74 |
Current Ratio
15.70
Quick Ratio
15.70
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 15.70 |
| 2026-03-31 | 37.75 |
| 2025-12-31 | 5.29 |
| 2025-09-30 | 4.98 |
| 2025-06-30 | 1.17 |
| 2025-03-31 | 0.67 |
| 2024-12-31 | 1.54 |
| 2024-09-30 | 2.30 |
| 2024-06-30 | 5.24 |
| 2024-03-31 | 4.84 |
| 2023-12-31 | 6.03 |
| 2023-09-30 | 2.20 |
| 2023-06-30 | 3.01 |
| 2023-03-31 | 3.10 |
| 2022-12-31 | 5.84 |
| 2022-09-30 | 10.93 |
| 2022-06-30 | 13.13 |
| 2022-03-31 | 11.17 |
| 2021-12-31 | 0.14 |
| 2021-09-30 | 0.06 |
| 2021-06-30 | 0.05 |
| 2021-03-31 | 0.02 |
| 2020-12-31 | 0.11 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
